import React, { useState } from 'react';
import { Calendar, User, Clock, ArrowRight, Search, Filter, BookOpen, Heart, Star, Sparkles, Tag, Share2, Eye } from 'lucide-react';

interface BlogPost {
  id: string;
  title: string;
  excerpt: string;
  content: string;
  author: string;
  date: string;
  readTime: string;
  category: string;
  tags: string[];
  image: string;
  views: number;
}

const BlogPage: React.FC = () => {
  const [selectedCategory, setSelectedCategory] = useState('All');
  const [searchTerm, setSearchTerm] = useState('');
  const [selectedPost, setSelectedPost] = useState<BlogPost | null>(null);

  const blogPosts: BlogPost[] = [
    {
      id: '1',
      title: 'The Future of Clinical Research: Emerging Trends and Technologies Transforming Healthcare',
      excerpt: 'Discover how artificial intelligence, machine learning, and digital health technologies are revolutionizing clinical research methodologies and accelerating drug development processes.',
      content: `
        <h2>Introduction to Modern Clinical Research</h2>
        <p>Clinical research stands at the forefront of medical advancement, serving as the bridge between laboratory discoveries and life-saving treatments. In recent years, the landscape of clinical research has undergone unprecedented transformation, driven by technological innovations, regulatory changes, and evolving patient expectations. This comprehensive exploration delves into the emerging trends that are reshaping how we conduct clinical trials, analyze data, and bring new therapies to market.</p>

        <h2>The Digital Revolution in Clinical Trials</h2>
        <p>The integration of digital technologies has fundamentally altered the clinical research paradigm. Electronic Data Capture (EDC) systems have replaced paper-based data collection, enabling real-time data monitoring and improved data quality. These systems facilitate seamless collaboration between research sites, sponsors, and regulatory authorities, significantly reducing the time from data collection to analysis.</p>

        <p>Remote monitoring capabilities have emerged as a game-changer, particularly highlighted during the COVID-19 pandemic. Virtual clinical trials, also known as decentralized clinical trials (DCTs), leverage telemedicine platforms, wearable devices, and mobile health applications to conduct studies without requiring participants to visit traditional research sites. This approach has dramatically improved patient recruitment and retention while reducing geographical barriers to participation.</p>

        <h2>Artificial Intelligence and Machine Learning Applications</h2>
        <p>Artificial Intelligence (AI) and Machine Learning (ML) are revolutionizing every aspect of clinical research. In drug discovery, AI algorithms can analyze vast molecular databases to identify potential therapeutic targets and predict drug interactions. Machine learning models help optimize clinical trial design by identifying optimal patient populations, predicting enrollment rates, and determining appropriate sample sizes.</p>

        <p>Natural Language Processing (NLP) technologies are transforming how researchers extract insights from unstructured clinical data, including physician notes, patient-reported outcomes, and literature reviews. These tools can identify adverse events, assess treatment responses, and generate real-world evidence more efficiently than traditional manual methods.</p>

        <h2>Precision Medicine and Biomarker-Driven Trials</h2>
        <p>The shift toward precision medicine has fundamentally changed clinical trial design. Biomarker-driven trials use genetic, molecular, or other biological markers to identify patients most likely to benefit from specific treatments. This approach not only improves treatment efficacy but also reduces the risk of adverse events and optimizes resource allocation.</p>

        <p>Companion diagnostics have become integral to drug development, enabling the identification of patient subgroups that respond favorably to targeted therapies. The integration of genomic sequencing, proteomics, and metabolomics data provides unprecedented insights into disease mechanisms and treatment responses.</p>

        <h2>Regulatory Innovation and Adaptive Trial Designs</h2>
        <p>Regulatory agencies worldwide are embracing innovative trial designs that allow for protocol modifications based on accumulating data. Adaptive clinical trials can adjust sample sizes, treatment arms, or patient populations during the study conduct, potentially reducing development timelines and costs while maintaining scientific rigor.</p>

        <p>The FDA's Breakthrough Therapy designation and the EMA's PRIME scheme provide accelerated pathways for promising treatments, enabling closer collaboration between sponsors and regulators throughout the development process. These initiatives have significantly reduced the time to market for critical therapies.</p>

        <h2>Patient-Centric Approaches and Engagement</h2>
        <p>Modern clinical research increasingly prioritizes patient experience and engagement. Patient-Reported Outcome Measures (PROMs) and Patient-Reported Experience Measures (PREMs) provide valuable insights into treatment effectiveness from the patient's perspective. Digital platforms enable continuous patient engagement, improving adherence and data quality.</p>

        <p>Patient advocacy groups play an increasingly important role in trial design, helping ensure that studies address meaningful endpoints and incorporate patient preferences. This collaborative approach has led to more relevant and impactful research outcomes.</p>

        <h2>Real-World Evidence and Post-Market Surveillance</h2>
        <p>The integration of real-world evidence (RWE) from electronic health records, claims databases, and patient registries is transforming how we understand treatment effectiveness and safety in routine clinical practice. RWE studies complement traditional randomized controlled trials by providing insights into treatment performance across diverse patient populations and healthcare settings.</p>

        <p>Advanced analytics platforms can continuously monitor safety signals and treatment outcomes, enabling proactive risk management and informed regulatory decision-making. This approach supports the development of risk evaluation and mitigation strategies (REMS) and facilitates post-market surveillance activities.</p>

        <h2>Global Collaboration and Data Sharing</h2>
        <p>International collaboration has become essential for addressing global health challenges. Harmonized regulatory standards, such as ICH guidelines, facilitate multinational clinical trials and accelerate global drug development. Data sharing initiatives enable researchers to leverage collective knowledge and avoid duplication of efforts.</p>

        <p>Blockchain technology is emerging as a solution for secure, transparent data sharing while maintaining patient privacy and data integrity. Smart contracts can automate compliance monitoring and ensure adherence to data sharing agreements.</p>

        <h2>Challenges and Future Directions</h2>
        <p>Despite significant advances, clinical research faces ongoing challenges including rising costs, lengthy development timelines, and increasing regulatory complexity. The industry must address issues related to data standardization, interoperability, and cybersecurity while maintaining the highest standards of patient safety and data integrity.</p>

        <p>Future developments will likely focus on further integration of AI and ML technologies, expansion of decentralized trial capabilities, and enhanced patient engagement strategies. The continued evolution of regulatory frameworks will be crucial for supporting innovation while ensuring patient safety and data quality.</p>

        <h2>Conclusion</h2>
        <p>The future of clinical research is bright, with emerging technologies and innovative approaches promising to accelerate the development of life-saving treatments while improving patient experiences. Success in this evolving landscape requires continuous learning, adaptation, and collaboration among all stakeholders. As we move forward, the integration of technology, patient-centricity, and regulatory innovation will continue to drive transformative changes in how we conduct clinical research and bring new therapies to patients in need.</p>

        <p>For healthcare professionals considering a career in clinical research, this dynamic field offers unprecedented opportunities to contribute to medical advancement while developing expertise in cutting-edge technologies and methodologies. The skills and knowledge gained through comprehensive training programs will be essential for navigating this exciting and rapidly evolving landscape.</p>
      `,
      author: 'Dr. Priya Sharma',
      date: '2024-01-15',
      readTime: '12 min read',
      category: 'Clinical Research',
      tags: ['AI in Healthcare', 'Digital Trials', 'Precision Medicine', 'Regulatory Innovation'],
      image: 'https://images.pexels.com/photos/3938023/pexels-photo-3938023.jpeg?auto=compress&cs=tinysrgb&w=800&h=600&fit=crop',
      views: 2847
    },
    {
      id: '2',
      title: 'Medical Coding Excellence: Mastering ICD-10, CPT, and HCPCS for Healthcare Documentation',
      excerpt: 'A comprehensive guide to medical coding systems, best practices, and career opportunities in healthcare documentation and revenue cycle management.',
      content: `
        <h2>Understanding the Foundation of Medical Coding</h2>
        <p>Medical coding serves as the universal language of healthcare, transforming complex medical diagnoses, procedures, and services into standardized alphanumeric codes. This critical process ensures accurate communication between healthcare providers, insurance companies, and government agencies while facilitating proper reimbursement and maintaining comprehensive health records. The precision and accuracy of medical coding directly impact healthcare organizations' financial stability and regulatory compliance.</p>

        <p>The evolution of medical coding has paralleled advances in medical knowledge and healthcare delivery systems. From simple classification systems to today's sophisticated coding frameworks, medical coding has become an essential component of modern healthcare infrastructure. Professional medical coders serve as the bridge between clinical care and administrative processes, ensuring that every patient encounter is accurately documented and appropriately reimbursed.</p>

        <h2>The ICD-10-CM System: Diagnostic Coding Excellence</h2>
        <p>The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) represents the most comprehensive diagnostic coding system ever developed. With over 68,000 diagnostic codes, ICD-10-CM provides unprecedented specificity in describing patient conditions, injuries, and diseases. This granular level of detail enables healthcare organizations to track disease patterns, monitor treatment outcomes, and support public health initiatives.</p>

        <p>ICD-10-CM codes follow a structured format that provides detailed information about the condition being coded. The first three characters represent the category, while subsequent characters provide increasing levels of specificity regarding anatomical location, severity, and other relevant clinical details. Understanding this hierarchical structure is essential for accurate code assignment and proper documentation.</p>

        <p>The coding guidelines for ICD-10-CM are extensive and require thorough understanding of medical terminology, anatomy, and disease processes. Coders must master concepts such as combination codes, sequencing rules, and the use of additional codes to capture comorbidities and complications. The Official Guidelines for Coding and Reporting provide authoritative guidance on proper code assignment and are regularly updated to reflect changes in medical practice and coding conventions.</p>

        <h2>CPT Coding: Capturing Procedures and Services</h2>
        <p>Current Procedural Terminology (CPT) codes, maintained by the American Medical Association, describe medical, surgical, and diagnostic procedures and services performed by healthcare providers. The CPT system consists of three categories: Category I codes for procedures and services, Category II codes for performance measurement, and Category III codes for emerging technologies and procedures.</p>

        <p>Category I CPT codes are organized into six main sections: Evaluation and Management, Anesthesia, Surgery, Radiology, Pathology and Laboratory, and Medicine. Each section has specific guidelines and conventions that govern code selection and modifier usage. Understanding these section-specific rules is crucial for accurate procedure coding and appropriate reimbursement.</p>

        <p>The complexity of CPT coding lies in understanding the relationships between different procedures, the appropriate use of modifiers, and the bundling and unbundling rules that govern code combinations. The National Correct Coding Initiative (NCCI) provides guidance on appropriate code combinations and helps prevent improper billing practices.</p>

        <h2>HCPCS Level II: Supplies, Equipment, and Services</h2>
        <p>Healthcare Common Procedure Coding System (HCPCS) Level II codes supplement CPT codes by describing supplies, equipment, and services not covered by CPT. These alphanumeric codes are essential for billing durable medical equipment, prosthetics, orthotics, supplies, and certain services provided by non-physician practitioners.</p>

        <p>HCPCS Level II codes are organized by categories, with each letter representing a different type of service or supply. For example, A codes represent transportation services and medical supplies, while E codes describe durable medical equipment. Understanding the appropriate use of HCPCS codes is essential for comprehensive medical coding and proper reimbursement for all healthcare services and supplies.</p>

        <h2>Medical Coding Accuracy and Quality Assurance</h2>
        <p>Accuracy in medical coding is paramount, as coding errors can result in claim denials, delayed payments, compliance issues, and potential legal consequences. Quality assurance programs in medical coding organizations typically include regular audits, continuing education requirements, and performance monitoring to ensure coding accuracy and compliance with regulatory requirements.</p>

        <p>The concept of coding accuracy encompasses several dimensions: diagnostic accuracy (correct identification and sequencing of diagnoses), procedural accuracy (appropriate selection of procedure codes and modifiers), and documentation accuracy (ensuring that coded information accurately reflects the clinical documentation). Achieving high levels of accuracy requires ongoing education, attention to detail, and thorough understanding of coding guidelines and conventions.</p>

        <h2>Technology and Medical Coding</h2>
        <p>Advances in technology are transforming the medical coding profession. Computer-Assisted Coding (CAC) systems use natural language processing and machine learning algorithms to suggest codes based on clinical documentation. While these systems can improve efficiency and consistency, human oversight remains essential to ensure accuracy and appropriate code selection.</p>

        <p>Electronic Health Records (EHRs) have revolutionized how medical coders access and review clinical documentation. Integration between EHR systems and coding software enables more efficient workflows and improved communication between clinical and coding staff. However, the quality of clinical documentation remains a critical factor in coding accuracy and completeness.</p>

        <h2>Compliance and Regulatory Considerations</h2>
        <p>Medical coding operates within a complex regulatory environment that includes federal and state laws, insurance regulations, and professional standards. The Health Insurance Portability and Accountability Act (HIPAA) establishes privacy and security requirements for protected health information, while the False Claims Act provides penalties for fraudulent billing practices.</p>

        <p>Compliance programs in healthcare organizations typically include policies and procedures for coding practices, regular training and education, monitoring and auditing activities, and corrective action procedures. Medical coders play a crucial role in maintaining compliance by following established guidelines and reporting potential compliance issues.</p>

        <h2>Career Opportunities in Medical Coding</h2>
        <p>The medical coding profession offers diverse career opportunities across various healthcare settings. Entry-level positions include medical coder, coding specialist, and health information technician. With experience and additional certifications, professionals can advance to roles such as coding supervisor, health information manager, compliance officer, or coding educator.</p>

        <p>Specialization opportunities exist in various medical specialties, including surgery, emergency medicine, radiology, and pathology. Each specialty has unique coding challenges and requirements, offering opportunities for professional growth and expertise development. Remote coding positions have become increasingly common, providing flexibility and work-life balance for many coding professionals.</p>

        <h2>Professional Certification and Continuing Education</h2>
        <p>Professional certification is essential for career advancement in medical coding. The American Academy of Professional Coders (AAPC) and the American Health Information Management Association (AHIMA) offer various certification programs, including Certified Professional Coder (CPC), Certified Coding Specialist (CCS), and specialty certifications in areas such as surgery and emergency medicine.</p>

        <p>Maintaining certification requires ongoing continuing education to stay current with coding changes, regulatory updates, and industry best practices. The medical coding field is constantly evolving, with annual updates to coding systems, new technologies, and changing healthcare delivery models requiring continuous learning and adaptation.</p>

        <h2>The Future of Medical Coding</h2>
        <p>The future of medical coding will be shaped by technological advances, regulatory changes, and evolving healthcare delivery models. Artificial intelligence and machine learning technologies will continue to enhance coding efficiency and accuracy, while new payment models and quality reporting requirements will create additional coding challenges and opportunities.</p>

        <p>The transition to value-based care models will require enhanced coding capabilities to capture quality metrics, patient outcomes, and risk adjustment factors. Medical coders will need to develop new skills and competencies to support these evolving requirements while maintaining the accuracy and compliance standards that are fundamental to the profession.</p>

        <h2>Conclusion</h2>
        <p>Medical coding represents a critical intersection of healthcare, technology, and business operations. Success in this field requires a combination of technical knowledge, attention to detail, and commitment to ongoing learning and professional development. As healthcare continues to evolve, medical coding professionals will play an increasingly important role in ensuring accurate documentation, appropriate reimbursement, and regulatory compliance.</p>

        <p>For individuals considering a career in medical coding, the field offers stability, growth opportunities, and the satisfaction of contributing to quality healthcare delivery. Comprehensive training programs provide the foundation for success, while ongoing education and professional development ensure continued career advancement in this dynamic and essential healthcare profession.</p>
      `,
      author: 'Rajesh Kumar',
      date: '2024-01-10',
      readTime: '15 min read',
      category: 'Medical Coding',
      tags: ['ICD-10', 'CPT Coding', 'HCPCS', 'Healthcare Documentation'],
      image: 'https://images.pexels.com/photos/4386466/pexels-photo-4386466.jpeg?auto=compress&cs=tinysrgb&w=800&h=600&fit=crop',
      views: 1923
    },
    {
      id: '3',
      title: 'Bioinformatics Revolution: Computational Biology Transforming Modern Medicine and Drug Discovery',
      excerpt: 'Explore how bioinformatics is revolutionizing personalized medicine, genomics research, and pharmaceutical development through advanced computational methods.',
      content: `
        <h2>The Emergence of Bioinformatics as a Transformative Science</h2>
        <p>Bioinformatics represents the convergence of biology, computer science, and information technology, creating a powerful discipline that is fundamentally transforming our understanding of life sciences. This interdisciplinary field applies computational methods to analyze and interpret biological data, enabling researchers to uncover patterns, relationships, and insights that would be impossible to discover through traditional experimental approaches alone.</p>

        <p>The exponential growth of biological data, driven by advances in high-throughput sequencing technologies, proteomics, and other omics sciences, has created an unprecedented need for sophisticated computational tools and analytical methods. Bioinformatics provides the essential infrastructure for managing, analyzing, and interpreting this vast amount of biological information, making it accessible and actionable for researchers, clinicians, and pharmaceutical companies worldwide.</p>

        <h2>Genomics and Next-Generation Sequencing</h2>
        <p>The completion of the Human Genome Project marked a watershed moment in biological research, but it was just the beginning of the genomics revolution. Next-Generation Sequencing (NGS) technologies have dramatically reduced the cost and time required for DNA sequencing, making whole-genome sequencing accessible for routine clinical and research applications.</p>

        <p>Bioinformatics tools and algorithms are essential for processing NGS data, which can generate terabytes of information from a single sequencing run. Quality control, read alignment, variant calling, and annotation require sophisticated computational pipelines that can handle the scale and complexity of modern genomic data. These tools enable researchers to identify disease-causing mutations, understand genetic variation, and develop personalized treatment strategies.</p>

        <p>The analysis of genomic data extends beyond simple sequence comparison to include structural variation analysis, copy number variation detection, and epigenomic profiling. Each of these applications requires specialized bioinformatics approaches and tools, highlighting the diverse and evolving nature of computational biology.</p>

        <h2>Proteomics and Protein Structure Analysis</h2>
        <p>While genomics provides the blueprint of life, proteomics reveals how that blueprint is executed. Proteins are the functional molecules that carry out most biological processes, and understanding their structure, function, and interactions is crucial for drug discovery and disease understanding. Bioinformatics plays a central role in proteomics research by providing tools for protein identification, quantification, and functional analysis.</p>

        <p>Mass spectrometry-based proteomics generates complex datasets that require sophisticated computational analysis. Protein identification algorithms compare experimental spectra against theoretical databases, while quantitative proteomics methods enable researchers to measure protein abundance changes across different conditions or disease states. These analyses provide insights into disease mechanisms and potential therapeutic targets.</p>

        <p>Protein structure prediction and analysis represent another critical application of bioinformatics. Computational methods can predict protein structures from amino acid sequences, identify functional domains, and model protein-protein interactions. These capabilities are essential for drug design and understanding how genetic variations affect protein function.</p>

        <h2>Systems Biology and Network Analysis</h2>
        <p>Systems biology takes a holistic approach to understanding biological systems by integrating data from multiple sources and levels of organization. Bioinformatics provides the computational framework for systems biology research, enabling the construction and analysis of biological networks that represent interactions between genes, proteins, metabolites, and other biological entities.</p>

        <p>Network analysis methods can identify key regulatory nodes, predict the effects of perturbations, and reveal emergent properties of biological systems. These approaches are particularly valuable for understanding complex diseases that involve multiple genes and pathways, such as cancer, diabetes, and neurological disorders.</p>

        <p>Pathway analysis tools enable researchers to interpret experimental results in the context of known biological pathways and processes. By mapping experimental data onto pathway databases, researchers can identify which biological processes are affected by specific treatments or disease conditions, providing insights into mechanisms of action and potential therapeutic targets.</p>

        <h2>Machine Learning and Artificial Intelligence in Bioinformatics</h2>
        <p>The integration of machine learning and artificial intelligence methods has revolutionized bioinformatics, enabling the analysis of increasingly complex and high-dimensional biological datasets. Deep learning algorithms can identify patterns in genomic sequences, predict protein structures, and classify disease subtypes with unprecedented accuracy.</p>

        <p>Supervised learning methods are used for tasks such as gene expression classification, protein function prediction, and drug response prediction. These approaches require training datasets with known outcomes and can achieve high accuracy when sufficient high-quality data is available. Unsupervised learning methods, such as clustering and dimensionality reduction, are valuable for exploratory data analysis and identifying hidden patterns in biological data.</p>

        <p>Natural language processing techniques are increasingly important for extracting information from the vast biomedical literature. Text mining tools can identify relationships between genes, diseases, and drugs, enabling researchers to generate hypotheses and discover new connections that might not be apparent from experimental data alone.</p>

        <h2>Personalized Medicine and Precision Healthcare</h2>
        <p>Bioinformatics is at the heart of the personalized medicine revolution, enabling the development of treatments tailored to individual patients based on their genetic makeup, lifestyle, and environmental factors. Pharmacogenomics, the study of how genetic variation affects drug response, relies heavily on bioinformatics tools to identify genetic markers associated with drug efficacy and toxicity.</p>

        <p>Clinical decision support systems integrate genomic data with clinical information to provide personalized treatment recommendations. These systems require sophisticated algorithms that can interpret complex genetic information and translate it into actionable clinical insights. The development of such systems requires close collaboration between bioinformaticians, clinicians, and regulatory experts.</p>

        <p>Companion diagnostics, which are tests designed to identify patients who are most likely to benefit from specific treatments, represent a key application of bioinformatics in personalized medicine. The development of companion diagnostics requires extensive bioinformatics analysis to identify and validate biomarkers that can predict treatment response.</p>

        <h2>Drug Discovery and Development</h2>
        <p>Bioinformatics has transformed pharmaceutical research and development by providing tools for target identification, lead compound optimization, and clinical trial design. Computational drug discovery methods can screen millions of compounds virtually, identifying promising candidates for experimental testing and reducing the time and cost of drug development.</p>

        <p>Structure-based drug design uses computational methods to model the interaction between drugs and their target proteins, enabling the rational design of new therapeutic compounds. These approaches can optimize drug properties such as potency, selectivity, and pharmacokinetics, improving the likelihood of clinical success.</p>

        <p>Bioinformatics also plays a crucial role in understanding drug mechanisms of action and identifying potential side effects. Network-based approaches can predict off-target effects and drug-drug interactions, helping to improve drug safety and efficacy.</p>

        <h2>Clinical Bioinformatics and Healthcare Applications</h2>
        <p>The translation of bioinformatics research into clinical practice requires specialized tools and workflows that can handle clinical-grade data and meet regulatory requirements. Clinical bioinformatics focuses on the development and implementation of computational methods for clinical applications, including diagnostic testing, treatment selection, and patient monitoring.</p>

        <p>Electronic health records (EHRs) represent a vast source of clinical data that can be analyzed using bioinformatics methods. Natural language processing tools can extract structured information from clinical notes, while machine learning algorithms can identify patterns associated with disease risk or treatment response.</p>

        <p>The integration of genomic data with clinical data presents both opportunities and challenges. While this integration can provide powerful insights into disease mechanisms and treatment options, it also requires careful attention to data privacy, security, and ethical considerations.</p>

        <h2>Data Management and Infrastructure</h2>
        <p>The scale and complexity of biological data require sophisticated data management systems and computational infrastructure. Cloud computing platforms have become essential for bioinformatics research, providing scalable storage and computing resources that can handle large-scale genomic analyses.</p>

        <p>Data standardization and interoperability are critical challenges in bioinformatics. The development of common data formats, ontologies, and standards enables data sharing and collaboration across research groups and institutions. Initiatives such as the FAIR (Findable, Accessible, Interoperable, Reusable) data principles provide guidelines for effective data management in bioinformatics.</p>

        <p>Reproducibility is a fundamental requirement for scientific research, and bioinformatics faces unique challenges in ensuring that computational analyses can be reproduced and validated. Workflow management systems, containerization technologies, and version control systems are essential tools for maintaining reproducible bioinformatics research.</p>

        <h2>Career Opportunities in Bioinformatics</h2>
        <p>The growing importance of bioinformatics has created diverse career opportunities across academia, industry, and healthcare. Entry-level positions include bioinformatics analyst, computational biologist, and data scientist roles in pharmaceutical companies, biotechnology firms, and research institutions.</p>

        <p>Specialized career paths exist in areas such as genomics, proteomics, structural biology, and clinical bioinformatics. Each specialization requires specific technical skills and domain knowledge, offering opportunities for professional growth and expertise development. Leadership roles in bioinformatics include research directors, principal scientists, and chief information officers in biotechnology and pharmaceutical companies.</p>

        <p>The interdisciplinary nature of bioinformatics means that professionals can come from diverse educational backgrounds, including biology, computer science, mathematics, and engineering. However, success in bioinformatics requires a combination of biological knowledge, computational skills, and statistical expertise.</p>

        <h2>Education and Training in Bioinformatics</h2>
        <p>Bioinformatics education has evolved rapidly to meet the growing demand for skilled professionals. Academic programs range from undergraduate concentrations to specialized graduate degrees in bioinformatics and computational biology. These programs typically combine coursework in biology, computer science, statistics, and mathematics with hands-on training in bioinformatics tools and methods.</p>

        <p>Professional development opportunities include workshops, online courses, and certification programs that focus on specific bioinformatics tools and applications. Many of these programs are designed for working professionals who want to transition into bioinformatics or expand their existing skills.</p>

        <p>Practical experience is essential for success in bioinformatics. Internships, research projects, and collaborative opportunities provide valuable hands-on experience with real biological datasets and research questions. Open-source bioinformatics projects also offer opportunities for skill development and community engagement.</p>

        <h2>Future Directions and Emerging Trends</h2>
        <p>The future of bioinformatics will be shaped by continued advances in sequencing technologies, computational methods, and our understanding of biological systems. Single-cell sequencing technologies are providing unprecedented insights into cellular heterogeneity and development, requiring new computational methods for analysis and interpretation.</p>

        <p>Multi-omics integration, which combines data from genomics, transcriptomics, proteomics, and other omics sciences, represents a major frontier in bioinformatics research. These approaches can provide comprehensive views of biological systems but require sophisticated computational methods to handle the complexity and scale of multi-dimensional data.</p>

        <p>The integration of bioinformatics with other emerging technologies, such as artificial intelligence, blockchain, and quantum computing, will create new opportunities and challenges. These technologies have the potential to revolutionize how we store, analyze, and interpret biological data.</p>

        <h2>Conclusion</h2>
        <p>Bioinformatics has emerged as an essential discipline that bridges the gap between biological research and computational science. Its applications span from basic research to clinical practice, driving advances in our understanding of life and the development of new therapeutic approaches. The field continues to evolve rapidly, driven by technological advances and the growing availability of biological data.</p>

        <p>For individuals interested in pursuing a career in bioinformatics, the field offers exciting opportunities to contribute to scientific discovery and medical advancement. Success requires a combination of biological knowledge, computational skills, and analytical thinking, along with a commitment to continuous learning and adaptation to new technologies and methods. As biological data continues to grow in scale and complexity, the importance of bioinformatics will only continue to increase, making it an excellent career choice for those interested in the intersection of biology and technology.</p>
      `,
      author: 'Dr. Ananya Patel',
      date: '2024-01-05',
      readTime: '18 min read',
      category: 'Bioinformatics',
      tags: ['Genomics', 'Computational Biology', 'Machine Learning', 'Drug Discovery'],
      image: 'https://images.pexels.com/photos/3825581/pexels-photo-3825581.jpeg?auto=compress&cs=tinysrgb&w=800&h=600&fit=crop',
      views: 3156
    },
    {
      id: '4',
      title: 'Healthcare Analytics and AI: Transforming Patient Care Through Data-Driven Insights',
      excerpt: 'Discover how artificial intelligence and advanced analytics are revolutionizing healthcare delivery, improving patient outcomes, and optimizing operational efficiency.',
      content: `
        <h2>The Data Revolution in Healthcare</h2>
        <p>Healthcare is experiencing an unprecedented transformation driven by the exponential growth of health data and the development of sophisticated analytical tools. Electronic health records, medical imaging, genomic sequencing, wearable devices, and remote monitoring systems generate vast amounts of data that hold the potential to revolutionize patient care, clinical decision-making, and healthcare operations.</p>

        <p>The integration of artificial intelligence and machine learning technologies with healthcare data is creating new opportunities to improve patient outcomes, reduce costs, and enhance the efficiency of healthcare delivery. This data-driven approach to healthcare represents a fundamental shift from reactive treatment models to proactive, predictive, and personalized care strategies.</p>

        <h2>Machine Learning Applications in Clinical Practice</h2>
        <p>Machine learning algorithms are being deployed across various clinical applications, from diagnostic imaging to treatment recommendation systems. In radiology, deep learning models can detect abnormalities in medical images with accuracy that often exceeds human radiologists, particularly for specific conditions such as diabetic retinopathy, skin cancer, and lung nodules.</p>

        <p>Natural language processing technologies are transforming how healthcare organizations extract insights from unstructured clinical data. These systems can analyze physician notes, discharge summaries, and other text-based medical records to identify patterns, extract relevant clinical information, and support clinical decision-making processes.</p>

        <p>Predictive analytics models can identify patients at risk for various conditions, including sepsis, heart failure, and hospital readmissions. These early warning systems enable healthcare providers to intervene proactively, potentially preventing adverse events and improving patient outcomes while reducing healthcare costs.</p>

        <h2>Precision Medicine and Genomic Analytics</h2>
        <p>The integration of genomic data with clinical information is enabling the development of precision medicine approaches that tailor treatments to individual patients based on their genetic makeup, lifestyle factors, and environmental exposures. Pharmacogenomics applications use genetic information to predict drug responses and optimize medication selection and dosing.</p>

        <p>Cancer genomics represents one of the most advanced applications of precision medicine, with tumor sequencing becoming routine in many oncology practices. Computational tools analyze genomic alterations in tumors to identify targeted therapy options and predict treatment responses, leading to more effective and less toxic cancer treatments.</p>

        <p>Population genomics studies leverage large-scale genetic datasets to identify disease risk factors, understand disease mechanisms, and develop new therapeutic targets. These studies require sophisticated computational infrastructure and analytical methods to handle the scale and complexity of genomic data.</p>

        <h2>Healthcare Operations and Resource Optimization</h2>
        <p>Healthcare analytics extends beyond clinical applications to include operational optimization and resource management. Predictive models can forecast patient demand, optimize staffing levels, and improve resource allocation across healthcare facilities. These applications help healthcare organizations operate more efficiently while maintaining high-quality patient care.</p>

        <p>Supply chain analytics help healthcare organizations optimize inventory management, reduce waste, and ensure the availability of critical supplies and medications. These systems can predict demand patterns, identify potential shortages, and optimize procurement strategies to reduce costs and improve efficiency.</p>

        <p>Revenue cycle analytics focus on optimizing billing processes, reducing claim denials, and improving financial performance. Machine learning models can identify patterns in claim data that predict denial risk, enabling proactive interventions to improve reimbursement rates and reduce administrative costs.</p>

        <h2>Population Health Management</h2>
        <p>Population health analytics enable healthcare organizations to understand and improve the health outcomes of entire patient populations. These approaches integrate data from multiple sources, including electronic health records, claims data, social determinants of health, and public health databases, to identify health trends and risk factors.</p>

        <p>Risk stratification models categorize patients based on their likelihood of developing specific conditions or requiring intensive healthcare services. These models enable healthcare organizations to target interventions and resources to high-risk populations, potentially preventing disease progression and reducing healthcare costs.</p>

        <p>Social determinants of health analytics examine how factors such as housing, education, income, and social support affect health outcomes. Understanding these relationships enables healthcare organizations to develop more comprehensive and effective interventions that address the root causes of health disparities.</p>

        <h2>Real-World Evidence and Comparative Effectiveness Research</h2>
        <p>Real-world evidence studies use data from routine clinical practice to evaluate treatment effectiveness, safety, and outcomes in diverse patient populations. These studies complement traditional randomized controlled trials by providing insights into how treatments perform in real-world settings with heterogeneous patient populations.</p>

        <p>Comparative effectiveness research uses advanced analytical methods to compare the effectiveness of different treatments or interventions using observational data. These studies can inform clinical guidelines, coverage decisions, and treatment recommendations by providing evidence about which treatments work best for specific patient populations.</p>

        <p>Post-market surveillance systems use real-world data to monitor the safety and effectiveness of medical devices, drugs, and other healthcare interventions after they enter the market. These systems can detect safety signals and effectiveness issues that may not have been apparent in pre-market clinical trials.</p>

        <h2>Digital Health and Remote Monitoring</h2>
        <p>The proliferation of digital health technologies, including wearable devices, mobile health applications, and remote monitoring systems, is generating new types of health data that require specialized analytical approaches. These technologies enable continuous monitoring of patient health status and can provide early warning signs of health deterioration.</p>

        <p>Remote patient monitoring systems use sensors and connected devices to track vital signs, medication adherence, and other health indicators outside of traditional healthcare settings. Analytics platforms process this continuous stream of data to identify trends, detect anomalies, and alert healthcare providers to potential issues.</p>

        <p>Digital therapeutics represent a new category of evidence-based interventions delivered through software applications. These interventions use behavioral analytics and machine learning to personalize treatment approaches and optimize patient engagement and outcomes.</p>

        <h2>Healthcare Data Integration and Interoperability</h2>
        <p>The effective use of healthcare analytics requires the integration of data from multiple sources and systems. Healthcare organizations often struggle with data silos, incompatible systems, and varying data formats that make comprehensive analytics challenging.</p>

        <p>Health information exchanges and interoperability standards, such as HL7 FHIR, are facilitating data sharing and integration across healthcare organizations. These standards enable the development of analytics platforms that can access and analyze data from multiple sources, providing more comprehensive insights into patient care and outcomes.</p>

        <p>Data governance frameworks ensure that healthcare analytics initiatives comply with privacy regulations, maintain data quality, and protect patient confidentiality. These frameworks are essential for building trust and ensuring the ethical use of healthcare data for analytics purposes.</p>

        <h2>Regulatory Considerations and Validation</h2>
        <p>The deployment of AI and analytics in healthcare is subject to regulatory oversight to ensure safety and effectiveness. The FDA has developed frameworks for regulating AI-based medical devices and software as medical devices (SaMD), providing guidance on validation requirements and approval processes.</p>

        <p>Clinical validation of AI and analytics systems requires rigorous testing to demonstrate safety, effectiveness, and clinical utility. This validation process often involves retrospective studies, prospective clinical trials, and real-world performance monitoring to ensure that these systems perform as intended in clinical practice.</p>

        <p>Bias detection and mitigation are critical considerations in healthcare AI development. Analytics systems must be tested across diverse patient populations to ensure that they perform equitably and do not perpetuate or amplify existing healthcare disparities.</p>

        <h2>Career Opportunities in Healthcare Analytics</h2>
        <p>The growing importance of healthcare analytics has created diverse career opportunities for professionals with the right combination of technical skills and healthcare knowledge. Data scientists, biostatisticians, health informatics specialists, and clinical analysts are in high demand across healthcare organizations, technology companies, and consulting firms.</p>

        <p>Specialized roles exist in areas such as clinical research analytics, population health analytics, and healthcare operations research. These positions require domain-specific knowledge and expertise in addition to general analytics skills, offering opportunities for professional specialization and career advancement.</p>

        <p>Leadership roles in healthcare analytics include chief data officers, directors of analytics, and heads of digital health initiatives. These positions require a combination of technical expertise, business acumen, and leadership skills to drive organizational transformation and innovation.</p>

        <h2>Education and Skill Development</h2>
        <p>Success in healthcare analytics requires a combination of technical skills, healthcare knowledge, and analytical thinking. Educational programs in health informatics, biostatistics, and data science provide foundational knowledge, while specialized training in healthcare analytics tools and methods builds practical skills.</p>

        <p>Programming skills in languages such as Python, R, and SQL are essential for healthcare analytics professionals. Knowledge of machine learning frameworks, statistical analysis software, and data visualization tools is also important for effective analytics work.</p>

        <p>Understanding healthcare operations, clinical workflows, and regulatory requirements is crucial for developing analytics solutions that are practical and implementable in healthcare settings. This domain knowledge often comes through experience working in healthcare organizations or through specialized healthcare informatics training.</p>

        <h2>Future Trends and Emerging Technologies</h2>
        <p>The future of healthcare analytics will be shaped by continued advances in AI technology, the growth of digital health data, and evolving healthcare delivery models. Federated learning approaches will enable analytics across multiple organizations while preserving data privacy and security.</p>

        <p>Edge computing and real-time analytics will enable more responsive healthcare systems that can provide immediate insights and interventions. These technologies will be particularly important for critical care applications and emergency response systems.</p>

        <p>The integration of social determinants of health data, environmental data, and other non-traditional health data sources will provide more comprehensive views of factors affecting health outcomes. This holistic approach to health analytics will enable more effective population health interventions and personalized care strategies.</p>

        <h2>Conclusion</h2>
        <p>Healthcare analytics and AI represent transformative technologies that have the potential to revolutionize healthcare delivery and improve patient outcomes. The successful implementation of these technologies requires careful attention to clinical validation, regulatory compliance, and ethical considerations, along with ongoing investment in education and skill development.</p>

        <p>For healthcare professionals and technologists interested in this field, healthcare analytics offers exciting opportunities to contribute to meaningful improvements in patient care and healthcare operations. The interdisciplinary nature of this field requires continuous learning and collaboration across multiple domains, making it an intellectually stimulating and rewarding career path.</p>

        <p>As healthcare continues to generate increasing amounts of data and adopt new technologies, the importance of healthcare analytics will only continue to grow. Organizations that successfully leverage these capabilities will be better positioned to provide high-quality, efficient, and personalized healthcare services in an increasingly complex and competitive healthcare environment.</p>
      `,
      author: 'Dr. Vikram Singh',
      date: '2023-12-28',
      readTime: '16 min read',
      category: 'Healthcare Technology',
      tags: ['Healthcare AI', 'Data Analytics', 'Machine Learning', 'Digital Health'],
      image: 'https://images.pexels.com/photos/3825581/pexels-photo-3825581.jpeg?auto=compress&cs=tinysrgb&w=800&h=600&fit=crop',
      views: 2734
    },
    {
      id: '5',
      title: 'Pharmacovigilance in the Digital Age: Advanced Safety Monitoring and Risk Management',
      excerpt: 'Explore how digital technologies and data analytics are transforming drug safety monitoring, adverse event detection, and risk management in pharmacovigilance.',
      content: `
        <h2>Evolution of Pharmacovigilance in Modern Healthcare</h2>
        <p>Pharmacovigilance, the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems, has undergone significant transformation in the digital age. Traditional pharmacovigilance relied heavily on spontaneous reporting systems and periodic safety updates, but modern approaches leverage advanced technologies, real-world data, and sophisticated analytical methods to enhance drug safety monitoring.</p>

        <p>The increasing complexity of modern therapeutics, including biologics, personalized medicines, and combination therapies, has created new challenges for safety monitoring that require innovative approaches and technologies. Digital pharmacovigilance represents a paradigm shift toward proactive, data-driven safety monitoring that can detect signals earlier, assess risks more accurately, and implement risk mitigation strategies more effectively.</p>

        <h2>Digital Data Sources and Real-World Evidence</h2>
        <p>The digital transformation of healthcare has created unprecedented opportunities for pharmacovigilance through the availability of diverse data sources. Electronic health records, claims databases, patient registries, and wearable devices generate continuous streams of real-world data that can be analyzed for safety signals and adverse events.</p>

        <p>Social media platforms and patient forums represent emerging data sources that can provide early insights into patient experiences and potential safety issues. Natural language processing technologies enable the extraction of adverse event information from unstructured text data, including patient posts, physician notes, and literature reports.</p>

        <p>Mobile health applications and patient-reported outcome tools enable direct collection of safety data from patients, providing more timely and comprehensive information about adverse events and their impact on patient quality of life. These digital tools can capture safety information that might not be reported through traditional healthcare channels.</p>

        <h2>Artificial Intelligence and Machine Learning in Signal Detection</h2>
        <p>Machine learning algorithms are revolutionizing signal detection in pharmacovigilance by enabling the analysis of large, complex datasets to identify potential safety signals that might be missed by traditional statistical methods. These algorithms can detect subtle patterns and associations in safety data that indicate emerging safety concerns.</p>

        <p>Natural language processing technologies automate the extraction and coding of adverse event information from various text sources, including case reports, literature, and social media. These tools can significantly improve the efficiency and consistency of adverse event processing while reducing the burden on pharmacovigilance professionals.</p>

        <p>Predictive modeling approaches use machine learning to identify patients at higher risk for specific adverse events based on their clinical characteristics, medication history, and other risk factors. These models enable proactive risk management and personalized safety monitoring strategies.</p>

        <h2>Advanced Analytics for Risk Assessment and Characterization</h2>
        <p>Modern pharmacovigilance employs sophisticated analytical methods to assess and characterize drug safety risks. Bayesian approaches enable the integration of prior knowledge with new safety data to provide more accurate risk estimates and support regulatory decision-making.</p>

        <p>Causal inference methods help distinguish between true drug-related adverse events and coincidental associations, improving the accuracy of safety assessments. These methods are particularly important for analyzing observational data where confounding factors may influence the apparent relationship between drug exposure and adverse events.</p>

        <p>Network analysis approaches examine the relationships between drugs, adverse events, and patient characteristics to identify patterns and mechanisms underlying drug safety issues. These analyses can reveal unexpected connections and provide insights into the biological basis of adverse drug reactions.</p>

        <h2>Regulatory Science and Digital Pharmacovigilance</h2>
        <p>Regulatory agencies worldwide are embracing digital technologies to enhance their pharmacovigilance capabilities and improve public health protection. The FDA's Sentinel System represents a pioneering example of a distributed data network that enables active surveillance of medical products using real-world data from multiple healthcare organizations.</p>

        <p>International harmonization efforts, such as the ICH E2B standard for electronic transmission of adverse event reports, facilitate global data sharing and improve the efficiency of safety monitoring across different regulatory jurisdictions. These standards enable the development of integrated global safety databases and analytical platforms.</p>

        <p>Regulatory agencies are developing new frameworks for evaluating and validating AI-based pharmacovigilance tools, ensuring that these technologies meet appropriate standards for accuracy, reliability, and clinical utility before implementation in regulatory decision-making processes.</p>

        <h2>Risk Evaluation and Mitigation Strategies (REMS)</h2>
        <p>Digital technologies are enhancing the design, implementation, and monitoring of Risk Evaluation and Mitigation Strategies (REMS) programs. Electronic prescribing systems can incorporate safety checks and educational materials to ensure appropriate prescribing and patient monitoring for high-risk medications.</p>

        <p>Patient registries and monitoring programs leverage digital platforms to track patient outcomes and assess the effectiveness of risk mitigation measures. These systems can provide real-time feedback on program performance and enable rapid adjustments to improve safety outcomes.</p>

        <p>Mobile applications and digital health tools can deliver targeted safety information and educational materials to patients and healthcare providers, improving awareness of drug risks and appropriate use practices. These tools can also facilitate the collection of safety data and patient-reported outcomes.</p>

        <h2>Global Pharmacovigilance and Data Sharing</h2>
        <p>The globalization of pharmaceutical development and marketing has created a need for coordinated international pharmacovigilance efforts. Digital platforms enable real-time sharing of safety data across different countries and regulatory agencies, improving the speed and effectiveness of global safety monitoring.</p>

        <p>Blockchain technology is being explored as a solution for secure, transparent, and immutable sharing of pharmacovigilance data across multiple stakeholders while maintaining data integrity and patient privacy. These systems could enable more efficient global safety monitoring while addressing concerns about data security and intellectual property protection.</p>

        <p>Collaborative initiatives, such as the Observational Health Data Sciences and Informatics (OHDSI) network, are developing common data models and analytical tools that enable standardized safety analyses across different healthcare databases and countries.</p>

        <h2>Patient Engagement and Participatory Pharmacovigilance</h2>
        <p>Digital technologies are enabling greater patient participation in pharmacovigilance through user-friendly reporting platforms, mobile applications, and social media monitoring. Patient-reported adverse events often provide valuable information about the real-world impact of medications that may not be captured in clinical trials or routine healthcare encounters.</p>

        <p>Crowdsourcing approaches leverage the collective knowledge and experiences of patient communities to identify potential safety signals and understand the patient perspective on drug risks and benefits. These approaches can provide early warnings about emerging safety issues and inform risk communication strategies.</p>

        <p>Digital health literacy programs help patients understand how to recognize, report, and manage adverse drug reactions, improving the quality and completeness of safety reporting while empowering patients to take an active role in their medication safety.</p>

        <h2>Challenges and Limitations of Digital Pharmacovigilance</h2>
        <p>Despite the significant advantages of digital pharmacovigilance, several challenges must be addressed to realize its full potential. Data quality and completeness remain significant concerns, particularly for real-world data sources that may have missing or inaccurate information.</p>

        <p>Privacy and security considerations are paramount when dealing with sensitive health information, requiring robust data protection measures and compliance with applicable regulations such as GDPR and HIPAA. Balancing the need for data sharing with privacy protection remains an ongoing challenge.</p>

        <p>The validation and regulatory acceptance of AI-based pharmacovigilance tools require extensive testing and evaluation to ensure that these systems perform reliably and provide clinically meaningful results. Establishing appropriate validation frameworks and performance standards is an active area of research and development.</p>

        <h2>Organizational Implementation and Change Management</h2>
        <p>The successful implementation of digital pharmacovigilance requires significant organizational changes, including new processes, technologies, and skill sets. Organizations must invest in training and development to ensure that pharmacovigilance professionals can effectively use new digital tools and analytical methods.</p>

        <p>Change management strategies must address resistance to new technologies and processes while ensuring that quality and compliance standards are maintained throughout the transition. Clear governance structures and accountability mechanisms are essential for successful digital transformation initiatives.</p>

        <p>Collaboration between pharmacovigilance professionals, data scientists, IT specialists, and regulatory experts is crucial for developing and implementing effective digital pharmacovigilance solutions. Cross-functional teams can ensure that technical capabilities are aligned with regulatory requirements and business objectives.</p>

        <h2>Career Opportunities in Digital Pharmacovigilance</h2>
        <p>The evolution of pharmacovigilance toward digital approaches has created new career opportunities for professionals with diverse backgrounds and skill sets. Traditional pharmacovigilance roles are expanding to include responsibilities for data analysis, technology implementation, and digital tool development.</p>

        <p>Specialized positions in areas such as pharmacovigilance data science, digital safety analytics, and AI-based signal detection are emerging as organizations seek professionals who can bridge the gap between traditional pharmacovigilance and modern data science approaches.</p>

        <p>Leadership roles in digital pharmacovigilance require a combination of pharmacovigilance expertise, technology knowledge, and change management skills. These positions involve strategic planning, technology evaluation, and organizational transformation initiatives.</p>

        <h2>Education and Professional Development</h2>
        <p>Professional development in digital pharmacovigilance requires continuous learning to keep pace with rapidly evolving technologies and methodologies. Traditional pharmacovigilance training programs are expanding to include modules on data science, AI applications, and digital health technologies.</p>

        <p>Certification programs and continuing education courses provide opportunities for pharmacovigilance professionals to develop new skills and stay current with industry trends. These programs often combine theoretical knowledge with hands-on training using real-world datasets and analytical tools.</p>

        <p>Cross-disciplinary collaboration and knowledge sharing are essential for advancing the field of digital pharmacovigilance. Professional organizations, conferences, and online communities provide platforms for sharing best practices, discussing challenges, and developing innovative solutions.</p>

        <h2>Future Directions and Emerging Trends</h2>
        <p>The future of pharmacovigilance will be shaped by continued advances in AI and machine learning, the growth of real-world data sources, and evolving regulatory frameworks. Federated learning approaches will enable collaborative analysis of safety data across multiple organizations while preserving data privacy and security.</p>

        <p>Integration with precision medicine approaches will enable personalized safety monitoring based on individual patient characteristics, genetic factors, and risk profiles. This personalized approach to pharmacovigilance could improve both safety and efficacy outcomes by tailoring monitoring strategies to individual patient needs.</p>

        <p>The development of automated pharmacovigilance systems that can continuously monitor safety data, detect signals, and generate regulatory reports with minimal human intervention represents a long-term goal for the field. These systems could significantly improve the speed and efficiency of safety monitoring while reducing costs and resource requirements.</p>

        <h2>Conclusion</h2>
        <p>Digital pharmacovigilance represents a fundamental transformation in how we monitor and manage drug safety in the modern healthcare environment. The integration of advanced technologies, real-world data, and sophisticated analytical methods is enabling more proactive, accurate, and efficient safety monitoring than ever before.</p>

        <p>Success in this evolving field requires a combination of traditional pharmacovigilance knowledge and new digital skills, along with an understanding of regulatory requirements and emerging technologies. Organizations that successfully embrace digital transformation will be better positioned to protect patient safety while supporting the development and appropriate use of innovative therapies.</p>

        <p>For professionals interested in pharmacovigilance careers, the digital transformation of the field offers exciting opportunities to contribute to patient safety while working with cutting-edge technologies and methodologies. The continued evolution of digital pharmacovigilance will require ongoing collaboration between diverse stakeholders to ensure that technological advances translate into meaningful improvements in drug safety and public health protection.</p>
      `,
      author: 'Dr. Meera Reddy',
      date: '2023-12-20',
      readTime: '14 min read',
      category: 'Pharmacovigilance',
      tags: ['Drug Safety', 'Digital Health', 'AI in Pharma', 'Risk Management'],
      image: 'https://images.pexels.com/photos/3938023/pexels-photo-3938023.jpeg?auto=compress&cs=tinysrgb&w=800&h=600&fit=crop',
      views: 1876
    },
    {
      id: '6',
      title: 'Regulatory Affairs Excellence: Navigating Global Healthcare Regulations and Compliance',
      excerpt: 'A comprehensive guide to regulatory affairs in healthcare, covering global regulatory frameworks, submission strategies, and compliance best practices.',
      content: `
        <h2>The Critical Role of Regulatory Affairs in Healthcare</h2>
        <p>Regulatory affairs serves as the essential bridge between pharmaceutical innovation and patient access to safe, effective treatments. This specialized field encompasses the strategic planning, preparation, and management of regulatory submissions, ensuring that medical products meet the stringent requirements of health authorities worldwide. Regulatory affairs professionals play a crucial role in bringing life-saving therapies to market while maintaining the highest standards of safety and efficacy.</p>

        <p>The complexity of modern healthcare regulation has grown exponentially with advances in biotechnology, personalized medicine, and digital health technologies. Regulatory affairs professionals must navigate an increasingly complex landscape of global regulations, evolving scientific standards, and changing regulatory expectations while supporting innovation and ensuring patient safety.</p>

        <h2>Global Regulatory Landscape and Harmonization</h2>
        <p>The global pharmaceutical industry operates within a complex web of regulatory frameworks that vary significantly across different regions and countries. Major regulatory agencies, including the FDA (United States), EMA (European Union), PMDA (Japan), and Health Canada, each have distinct requirements and processes for drug approval and oversight.</p>

        <p>International harmonization efforts, led by organizations such as the International Council for Harmonisation (ICH), aim to streamline regulatory requirements and reduce duplication of effort in global drug development. ICH guidelines cover areas such as quality, safety, efficacy, and multidisciplinary topics, providing a foundation for consistent regulatory standards across major markets.</p>

        <p>Regional initiatives, such as the African Medicines Regulatory Harmonisation (AMRH) program and the Association of Southeast Asian Nations (ASEAN) pharmaceutical harmonization efforts, are working to align regulatory standards and facilitate market access in emerging economies. These initiatives are crucial for ensuring global access to essential medicines and supporting local pharmaceutical development.</p>

        <h2>Drug Development and Regulatory Strategy</h2>
        <p>Effective regulatory strategy begins early in the drug development process, with regulatory affairs professionals working closely with research and development teams to ensure that clinical programs are designed to meet regulatory requirements. This strategic approach helps minimize development risks, optimize study designs, and accelerate time to market.</p>

        <p>Regulatory pathway selection is a critical strategic decision that can significantly impact development timelines and costs. Special regulatory pathways, such as breakthrough therapy designation, fast track designation, and orphan drug designation, provide opportunities for accelerated development and review for products that address unmet medical needs.</p>

        <p>Scientific advice and regulatory guidance meetings with health authorities provide valuable opportunities to align development strategies with regulatory expectations. These interactions help clarify regulatory requirements, discuss novel approaches, and address potential challenges before they become obstacles to approval.</p>

        <h2>Clinical Development and Regulatory Oversight</h2>
        <p>Regulatory affairs professionals play a crucial role in clinical development by ensuring that clinical trials are conducted in compliance with Good Clinical Practice (GCP) guidelines and applicable regulations. This includes oversight of protocol development, investigator selection, and safety reporting requirements.</p>

        <p>Investigational New Drug (IND) applications and Clinical Trial Applications (CTAs) require careful preparation and ongoing maintenance to ensure compliance with regulatory requirements. Regulatory affairs professionals must monitor changing regulations and ensure that clinical programs adapt to new requirements as they emerge.</p>

        <p>Safety reporting and risk management are critical components of clinical development oversight. Regulatory affairs professionals must ensure that adverse events are properly reported to health authorities and that risk mitigation strategies are implemented when necessary to protect patient safety.</p>

        <h2>Marketing Authorization and Product Approval</h2>
        <p>The preparation and submission of marketing authorization applications represent the culmination of years of development effort and require meticulous attention to detail and regulatory expertise. New Drug Applications (NDAs), Biologics License Applications (BLAs), and Marketing Authorization Applications (MAAs) must present comprehensive evidence of safety and efficacy while addressing all regulatory requirements.</p>

        <p>Regulatory writing and document preparation require specialized skills to present complex scientific and clinical data in a clear, compelling manner that addresses regulatory questions and concerns. High-quality regulatory documents are essential for successful regulatory review and approval.</p>

        <p>Regulatory review management involves ongoing communication with health authorities throughout the review process, including responses to regulatory questions, participation in advisory committee meetings, and negotiation of labeling and post-market commitments.</p>

        <h2>Post-Market Regulatory Activities</h2>
        <p>Regulatory responsibilities continue after product approval through post-market surveillance, safety monitoring, and lifecycle management activities. Post-market studies, risk evaluation and mitigation strategies (REMS), and periodic safety updates ensure ongoing monitoring of product safety and effectiveness in real-world use.</p>

        <p>Regulatory compliance monitoring ensures that marketed products continue to meet regulatory requirements and that any changes to manufacturing, labeling, or indications are properly approved by health authorities. This includes management of regulatory commitments and timelines established during the approval process.</p>

        <p>Product lifecycle management involves strategic planning for product enhancements, line extensions, and new indications that can extend product value and improve patient outcomes. Regulatory affairs professionals must evaluate the regulatory implications of lifecycle strategies and develop appropriate submission plans.</p>

        <h2>Quality and Manufacturing Regulations</h2>
        <p>Good Manufacturing Practice (GMP) regulations ensure that pharmaceutical products are consistently produced and controlled according to quality standards appropriate for their intended use. Regulatory affairs professionals must understand GMP requirements and work closely with manufacturing and quality teams to ensure compliance.</p>

        <p>Pharmaceutical quality systems encompass all aspects of product quality, from raw material sourcing to finished product release. Regulatory affairs professionals must ensure that quality systems meet regulatory requirements and support product approval and commercialization activities.</p>

        <p>Supply chain management and regulatory compliance involve oversight of contract manufacturers, suppliers, and distributors to ensure that all parties meet applicable regulatory requirements. This includes qualification of suppliers, audit oversight, and management of regulatory agreements.</p>

        <h2>Digital Health and Emerging Technologies</h2>
        <p>The rapid growth of digital health technologies, including software as medical devices (SaMD), artificial intelligence, and digital therapeutics, has created new regulatory challenges and opportunities. Regulatory frameworks for these technologies are still evolving, requiring regulatory affairs professionals to stay current with emerging guidance and requirements.</p>

        <p>Combination products that include both traditional pharmaceutical components and digital technologies require specialized regulatory expertise to navigate the complex approval pathways and ensure appropriate oversight by relevant regulatory authorities.</p>

        <p>Data integrity and cybersecurity considerations are becoming increasingly important as pharmaceutical companies adopt digital technologies and cloud-based systems. Regulatory affairs professionals must ensure that these systems meet regulatory requirements for data integrity, security, and patient privacy.</p>

        <h2>Regulatory Intelligence and Strategic Planning</h2>
        <p>Regulatory intelligence involves the systematic collection, analysis, and interpretation of regulatory information to support strategic decision-making. This includes monitoring regulatory developments, analyzing competitive landscapes, and identifying opportunities and risks that could impact product development and commercialization strategies.</p>

        <p>Competitive intelligence and market analysis help regulatory affairs professionals understand the regulatory strategies of competitors and identify best practices that can be applied to their own programs. This information is valuable for strategic planning and risk assessment.</p>

        <p>Regulatory forecasting and scenario planning enable organizations to anticipate future regulatory changes and prepare appropriate response strategies. This proactive approach helps minimize the impact of regulatory changes on development programs and commercial operations.</p>

        <h2>Regulatory Affairs Organization and Management</h2>
        <p>Effective regulatory affairs organizations require clear governance structures, defined roles and responsibilities, and robust processes for managing regulatory activities. This includes establishment of regulatory committees, decision-making frameworks, and communication protocols that ensure alignment across the organization.</p>

        <p>Regulatory project management involves coordination of complex, multi-disciplinary activities with strict timelines and regulatory requirements. Project management skills are essential for successful regulatory affairs professionals, particularly for managing large submission projects and global regulatory strategies.</p>

        <p>Cross-functional collaboration is critical for regulatory affairs success, requiring effective communication and partnership with research and development, clinical operations, manufacturing, quality, commercial, and legal teams. Regulatory affairs professionals must be able to translate regulatory requirements into actionable business strategies.</p>

        <h2>Career Development in Regulatory Affairs</h2>
        <p>Regulatory affairs offers diverse career opportunities across pharmaceutical, biotechnology, medical device, and consulting organizations. Entry-level positions include regulatory affairs associate, regulatory specialist, and regulatory coordinator roles that provide foundational experience in regulatory processes and requirements.</p>

        <p>Career advancement opportunities include senior regulatory affairs roles, regulatory affairs management positions, and specialized roles in areas such as regulatory strategy, regulatory intelligence, and regulatory operations. Leadership positions include director and vice president roles that involve strategic planning and organizational management.</p>

        <p>Specialization opportunities exist in various therapeutic areas, product types, and regulatory functions. Specialists in areas such as oncology, rare diseases, biologics, and digital health are in high demand as these areas continue to grow and evolve.</p>

        <h2>Education and Professional Development</h2>
        <p>Success in regulatory affairs requires a combination of scientific knowledge, regulatory expertise, and business acumen. Educational backgrounds in life sciences, pharmacy, medicine, or related fields provide a strong foundation, while specialized training in regulatory affairs develops the specific skills needed for success in the field.</p>

        <p>Professional certification programs, such as those offered by the Regulatory Affairs Professionals Society (RAPS), provide structured learning opportunities and demonstrate professional competency. These programs cover core regulatory affairs topics and are regularly updated to reflect current practices and requirements.</p>

        <p>Continuing education is essential in regulatory affairs due to the constantly evolving regulatory landscape. Professional development opportunities include conferences, workshops, webinars, and online courses that provide updates on regulatory changes and best practices.</p>

        <h2>Future Trends and Emerging Challenges</h2>
        <p>The future of regulatory affairs will be shaped by continued advances in biotechnology, the growth of personalized medicine, and the increasing importance of real-world evidence in regulatory decision-making. Regulatory frameworks will need to evolve to accommodate these advances while maintaining appropriate safety and efficacy standards.</p>

        <p>Artificial intelligence and machine learning technologies are beginning to impact regulatory affairs through applications such as automated document preparation, regulatory intelligence, and predictive analytics. These technologies have the potential to improve efficiency and accuracy while reducing costs and timelines.</p>

        <p>Global health initiatives and access to medicines programs are creating new opportunities and challenges for regulatory affairs professionals. Ensuring that innovative therapies are accessible to patients in low- and middle-income countries requires specialized regulatory strategies and collaborative approaches.</p>

        <h2>Conclusion</h2>
        <p>Regulatory affairs represents a critical function that enables the development and commercialization of safe, effective medical products while ensuring compliance with complex global regulatory requirements. The field offers rewarding career opportunities for professionals who are passionate about improving patient health and contributing to medical innovation.</p>

        <p>Success in regulatory affairs requires a combination of scientific knowledge, regulatory expertise, strategic thinking, and communication skills. The constantly evolving regulatory landscape provides ongoing challenges and learning opportunities that make regulatory affairs an intellectually stimulating and professionally rewarding career choice.</p>

        <p>As the pharmaceutical industry continues to innovate and expand globally, the importance of regulatory affairs will only continue to grow. Organizations that invest in regulatory affairs expertise and capabilities will be better positioned to navigate regulatory challenges, accelerate product development, and ultimately improve patient outcomes through innovative therapies and medical technologies.</p>
      `,
      author: 'Arjun Nair',
      date: '2023-12-15',
      readTime: '17 min read',
      category: 'Regulatory Affairs',
      tags: ['FDA Regulations', 'Global Compliance', 'Drug Approval', 'Regulatory Strategy'],
      image: 'https://images.pexels.com/photos/3938023/pexels-photo-3938023.jpeg?auto=compress&cs=tinysrgb&w=800&h=600&fit=crop',
      views: 2145
    }
  ];

  const categories = ['All', 'Clinical Research', 'Medical Coding', 'Bioinformatics', 'Healthcare Technology', 'Pharmacovigilance', 'Regulatory Affairs'];

  const filteredPosts = blogPosts.filter(post => {
    const matchesCategory = selectedCategory === 'All' || post.category === selectedCategory;
    const matchesSearch = post.title.toLowerCase().includes(searchTerm.toLowerCase()) ||
                         post.excerpt.toLowerCase().includes(searchTerm.toLowerCase()) ||
                         post.tags.some(tag => tag.toLowerCase().includes(searchTerm.toLowerCase()));
    return matchesCategory && matchesSearch;
  });

  const handleReadMore = (post: BlogPost) => {
    setSelectedPost(post);
  };

  const handleBackToList = () => {
    setSelectedPost(null);
  };

  const sharePost = (post: BlogPost) => {
    if (navigator.share) {
      navigator.share({
        title: post.title,
        text: post.excerpt,
        url: window.location.href
      });
    } else {
      // Fallback for browsers that don't support Web Share API
      navigator.clipboard.writeText(window.location.href);
      alert('Link copied to clipboard!');
    }
  };

  if (selectedPost) {
    return (
      <div className="min-h-screen bg-gradient-to-br from-white via-slate-50 to-blue-50">
        {/* Article Header */}
        <div className="bg-gradient-to-r from-blue-600 to-indigo-600 text-white py-16 relative overflow-hidden">
          <div className="absolute inset-0 opacity-20">
            <img 
              src={selectedPost.image} 
              alt={selectedPost.title} 
              className="w-full h-full object-cover object-center"
            />
            <div className="absolute inset-0 bg-gradient-to-r from-blue-600/80 via-blue-600/60 to-indigo-600/80"></div>
          </div>

          <div className="relative max-w-4xl mx-auto px-4 sm:px-6 lg:px-8">
            <button 
              onClick={handleBackToList}
              className="flex items-center text-white/80 hover:text-white mb-6 transition-colors"
            >
              <ArrowRight className="rotate-180 mr-2" size={20} />
              Back to Articles
            </button>
            
            <div className="mb-6">
              <span className="bg-white/20 backdrop-blur-md text-white px-4 py-2 rounded-full text-sm font-semibold">
                {selectedPost.category}
              </span>
            </div>
            
            <h1 className="text-3xl md:text-5xl font-bold mb-6 leading-tight font-poppins">
              {selectedPost.title}
            </h1>
            
            <div className="flex flex-wrap items-center gap-6 text-white/90">
              <div className="flex items-center">
                <User size={16} className="mr-2" />
                <span className="font-medium">{selectedPost.author}</span>
              </div>
              <div className="flex items-center">
                <Calendar size={16} className="mr-2" />
                <span>{new Date(selectedPost.date).toLocaleDateString('en-US', { year: 'numeric', month: 'long', day: 'numeric' })}</span>
              </div>
              <div className="flex items-center">
                <Clock size={16} className="mr-2" />
                <span>{selectedPost.readTime}</span>
              </div>
              <div className="flex items-center">
                <Eye size={16} className="mr-2" />
                <span>{selectedPost.views.toLocaleString()} views</span>
              </div>
            </div>
          </div>
        </div>

        {/* Article Content */}
        <div className="max-w-4xl mx-auto px-4 sm:px-6 lg:px-8 py-16">
          <div className="bg-white/60 backdrop-blur-lg rounded-3xl p-8 md:p-12 border border-white/20 shadow-lg">
            {/* Article Tags */}
            <div className="flex flex-wrap gap-2 mb-8">
              {selectedPost.tags.map((tag, index) => (
                <span key={index} className="bg-blue-100 text-blue-700 px-3 py-1 rounded-full text-sm font-medium">
                  <Tag size={12} className="inline mr-1" />
                  {tag}
                </span>
              ))}
            </div>

            {/* Article Body */}
            <div 
              className="prose prose-lg max-w-none"
              dangerouslySetInnerHTML={{ __html: selectedPost.content }}
              style={{
                lineHeight: '1.8',
                fontSize: '1.1rem'
              }}
            />

            {/* Share and Actions */}
            <div className="mt-12 pt-8 border-t border-gray-200">
              <div className="flex items-center justify-between">
                <div className="flex items-center space-x-4">
                  <button 
                    onClick={() => sharePost(selectedPost)}
                    className="flex items-center space-x-2 bg-blue-600 text-white px-6 py-3 rounded-full hover:bg-blue-700 transition-colors"
                  >
                    <Share2 size={16} />
                    <span>Share Article</span>
                  </button>
                </div>
                <div className="text-gray-600">
                  <Eye size={16} className="inline mr-1" />
                  {selectedPost.views.toLocaleString()} views
                </div>
              </div>
            </div>
          </div>

          {/* Related Articles */}
          <div className="mt-16">
            <h3 className="text-2xl font-bold text-gray-900 mb-8">Related Articles</h3>
            <div className="grid grid-cols-1 md:grid-cols-2 gap-8">
              {blogPosts
                .filter(post => post.id !== selectedPost.id && post.category === selectedPost.category)
                .slice(0, 2)
                .map((post) => (
                  <div key={post.id} className="bg-white/60 backdrop-blur-lg rounded-3xl overflow-hidden border border-white/20 shadow-lg hover:shadow-xl transition-all duration-300 cursor-pointer" onClick={() => handleReadMore(post)}>
                    <img src={post.image} alt={post.title} className="w-full h-48 object-cover" />
                    <div className="p-6">
                      <h4 className="text-lg font-bold text-gray-900 mb-2 line-clamp-2">{post.title}</h4>
                      <p className="text-gray-600 text-sm mb-4 line-clamp-2">{post.excerpt}</p>
                      <div className="flex items-center justify-between text-sm text-gray-500">
                        <span>{post.author}</span>
                        <span>{post.readTime}</span>
                      </div>
                    </div>
                  </div>
                ))}
            </div>
          </div>
        </div>
      </div>
    );
  }

  return (
    <div className="min-h-screen bg-gradient-to-br from-white via-slate-50 to-blue-50">
      {/* Header Section */}
      <div className="bg-gradient-to-r from-blue-600 to-indigo-600 text-white py-16 relative overflow-hidden">
        <div className="absolute inset-0 opacity-20">
          <img 
            src="https://images.pexels.com/photos/3938023/pexels-photo-3938023.jpeg?auto=compress&cs=tinysrgb&w=1920&h=1080&fit=crop" 
            alt="Healthcare Blog" 
            className="w-full h-full object-cover object-center"
          />
          <div className="absolute inset-0 bg-gradient-to-r from-blue-600/80 via-blue-600/60 to-indigo-600/80"></div>
        </div>

        {/* Floating decorative elements */}
        <div className="absolute inset-0 pointer-events-none">
          <Heart className="absolute top-20 right-1/4 text-pink-400 opacity-40 animate-bounce" size={24} style={{ animationDelay: '0s', animationDuration: '4s' }} />
          <Star className="absolute bottom-32 left-1/5 text-yellow-400 opacity-50 animate-bounce" size={28} style={{ animationDelay: '1s', animationDuration: '3.5s' }} />
          <Sparkles className="absolute top-1/3 left-1/6 text-purple-400 opacity-40 animate-bounce" size={20} style={{ animationDelay: '2s', animationDuration: '4.2s' }} />
          <BookOpen className="absolute top-2/3 right-1/6 text-white opacity-30 animate-bounce" size={26} style={{ animationDelay: '1.5s', animationDuration: '3.8s' }} />
        </div>

        <div className="relative max-w-7xl mx-auto px-4 sm:px-6 lg:px-8">
          <div className="text-center">
            <h1 className="text-3xl md:text-6xl font-bold mb-6 font-poppins">
              Healthcare <span className="text-yellow-400">Insights</span>
            </h1>
            <p className="text-lg md:text-xl text-white/90 mb-8 max-w-3xl mx-auto font-poppins">
              Stay updated with the latest trends, insights, and developments in healthcare, clinical research, and medical technology
            </p>
          </div>
        </div>
      </div>

      <div className="max-w-7xl mx-auto px-4 sm:px-6 lg:px-8 py-16">
        {/* Search and Filter Section */}
        <div className="bg-white/60 backdrop-blur-lg rounded-3xl p-8 border border-white/20 shadow-lg mb-12">
          <div className="flex flex-col lg:flex-row gap-6">
            {/* Search Bar */}
            <div className="flex-1 relative">
              <Search className="absolute left-4 top-1/2 transform -translate-y-1/2 text-gray-400" size={20} />
              <input
                type="text"
                placeholder="Search articles..."
                value={searchTerm}
                onChange={(e) => setSearchTerm(e.target.value)}
                className="w-full pl-12 pr-4 py-3 bg-white/50 backdrop-blur-md border border-white/30 rounded-2xl focus:ring-2 focus:ring-blue-500 focus:border-transparent focus:bg-white/70 transition-all duration-300 font-poppins"
              />
            </div>

            {/* Category Filter */}
            <div className="lg:w-64">
              <select
                value={selectedCategory}
                onChange={(e) => setSelectedCategory(e.target.value)}
                className="w-full px-4 py-3 bg-white/50 backdrop-blur-md border border-white/30 rounded-2xl focus:ring-2 focus:ring-blue-500 focus:border-transparent focus:bg-white/70 transition-all duration-300 font-poppins"
              >
                {categories.map((category) => (
                  <option key={category} value={category}>{category}</option>
                ))}
              </select>
            </div>
          </div>
        </div>

        {/* Blog Posts Grid */}
        <div className="grid grid-cols-1 md:grid-cols-2 lg:grid-cols-3 gap-8">
          {filteredPosts.map((post) => (
            <article key={post.id} className="bg-white/60 backdrop-blur-lg rounded-3xl overflow-hidden border border-white/20 shadow-lg hover:shadow-2xl hover:bg-white/80 hover:scale-105 transition-all duration-500 group">
              <div className="relative">
                <img src={post.image} alt={post.title} className="w-full h-48 object-cover group-hover:scale-110 transition-transform duration-500" />
                <div className="absolute top-4 left-4 bg-gradient-to-r from-blue-600 to-indigo-600 text-white px-3 py-1 rounded-full text-sm font-semibold">
                  {post.category}
                </div>
                <div className="absolute bottom-4 right-4 bg-black/50 backdrop-blur-md text-white px-2 py-1 rounded-lg text-xs">
                  <Eye size={12} className="inline mr-1" />
                  {post.views.toLocaleString()}
                </div>
              </div>
              
              <div className="p-6">
                <h2 className="text-xl font-bold text-gray-900 mb-3 group-hover:text-blue-600 transition-colors line-clamp-2 font-poppins">
                  {post.title}
                </h2>
                
                <p className="text-gray-600 mb-4 line-clamp-3 leading-relaxed font-poppins">
                  {post.excerpt}
                </p>
                
                <div className="flex flex-wrap gap-2 mb-4">
                  {post.tags.slice(0, 2).map((tag, index) => (
                    <span key={index} className="bg-blue-100 text-blue-700 px-2 py-1 rounded-full text-xs font-medium">
                      {tag}
                    </span>
                  ))}
                  {post.tags.length > 2 && (
                    <span className="bg-gray-100 text-gray-600 px-2 py-1 rounded-full text-xs">
                      +{post.tags.length - 2} more
                    </span>
                  )}
                </div>
                
                <div className="flex items-center justify-between text-sm text-gray-500 mb-4">
                  <div className="flex items-center">
                    <User size={14} className="mr-1" />
                    <span className="font-poppins">{post.author}</span>
                  </div>
                  <div className="flex items-center">
                    <Clock size={14} className="mr-1" />
                    <span className="font-poppins">{post.readTime}</span>
                  </div>
                </div>
                
                <div className="flex items-center justify-between">
                  <span className="text-xs text-gray-500 font-poppins">
                    {new Date(post.date).toLocaleDateString('en-US', { year: 'numeric', month: 'short', day: 'numeric' })}
                  </span>
                  <button 
                    onClick={() => handleReadMore(post)}
                    className="bg-gradient-to-r from-blue-600 to-indigo-600 text-white px-4 py-2 rounded-full hover:from-blue-700 hover:to-indigo-700 transition-all duration-300 flex items-center space-x-2 text-sm font-poppins"
                  >
                    <span>Read More</span>
                    <ArrowRight size={14} />
                  </button>
                </div>
              </div>
            </article>
          ))}
        </div>

        {/* No Results */}
        {filteredPosts.length === 0 && (
          <div className="text-center py-16">
            <BookOpen className="mx-auto mb-4 text-gray-400" size={64} />
            <h3 className="text-2xl font-bold text-gray-900 mb-2 font-poppins">No articles found</h3>
            <p className="text-gray-600 mb-6 font-poppins">Try adjusting your search terms or category filter</p>
            <button
              onClick={() => {
                setSearchTerm('');
                setSelectedCategory('All');
              }}
              className="bg-blue-600 text-white px-6 py-3 rounded-full hover:bg-blue-700 transition-colors font-poppins"
            >
              Clear Filters
            </button>
          </div>
        )}

        {/* Newsletter Signup */}
        <div className="mt-16 bg-gradient-to-r from-blue-600 to-indigo-600 text-white rounded-3xl p-12 shadow-2xl">
          <div className="text-center">
            <h2 className="text-2xl md:text-3xl font-bold mb-4 font-poppins">Stay Updated</h2>
            <p className="text-lg md:text-xl text-white/90 mb-8 font-poppins">
              Subscribe to our newsletter for the latest healthcare insights and industry updates
            </p>
            <div className="flex flex-col sm:flex-row gap-4 justify-center max-w-md mx-auto">
              <input
                type="email"
                placeholder="Enter your email"
                className="flex-1 px-6 py-3 rounded-full text-gray-900 focus:outline-none focus:ring-2 focus:ring-white/50 font-poppins"
              />
              <button className="bg-white text-blue-600 px-8 py-3 rounded-full font-semibold hover:bg-gray-100 transition-colors font-poppins">
                Subscribe
              </button>
            </div>
          </div>
        </div>
      </div>
    </div>
  );
};

export default BlogPage;